Vitro Biopharma Inc (DELISTED) (VTRO:DL)
Vitro Biopharma Cash from Operations (TTM): -2.820M for July 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
July 31, 2023 | -2.820M |
April 30, 2023 | -2.632M |
Date | Value |
---|---|
January 31, 2023 | -2.408M |
October 31, 2022 | -2.217M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.820M
Minimum
Jul 2023
-2.217M
Maximum
Oct 2022
-2.519M
Average
-2.520M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -9.515M |
Asensus Surgical Inc | -63.63M |
Senseonics Holdings Inc | -70.16M |